These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2589390)

  • 1. Ciprofloxacin pharmacokinetics in critically ill trauma patients.
    Yuen GJ; Drusano GL; Plaisance K; Forrest A; Caplan ES
    Am J Med; 1989 Nov; 87(5A):70S-75S. PubMed ID: 2589390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective use of optimal sampling theory: steady-state ciprofloxacin pharmacokinetics in critically ill trauma patients.
    Yuen GJ; Drusano GL; Forrest A; Plaisance K; Caplan ES
    Clin Pharmacol Ther; 1989 Oct; 46(4):451-7. PubMed ID: 2791447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An overview of the pharmacology of intravenously administered ciprofloxacin.
    Drusano GL
    Am J Med; 1987 Apr; 82(4A):339-45. PubMed ID: 3578325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic Study of Intravenous Acetaminophen Administered to Critically Ill Multiple-Trauma Patients at the Usual Dosage and a New Proposal for Administration.
    Fuster-Lluch O; Zapater-Hernández P; Gerónimo-Pardo M
    J Clin Pharmacol; 2017 Oct; 57(10):1345-1352. PubMed ID: 28419483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral ciprofloxacin in the treatment of serious soft tissue and bone infections. Efficacy, safety, and pharmacokinetics.
    Nix DE; Cumbo TJ; Kuritzky P; DeVito JM; Schentag JJ
    Am J Med; 1987 Apr; 82(4A):146-53. PubMed ID: 3555029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of equal doses of continuous venovenous haemofiltration and haemodiafiltration on ciprofloxacin population pharmacokinetics in critically ill patients.
    Roger C; Wallis SC; Louart B; Lefrant JY; Lipman J; Muller L; Roberts JA
    J Antimicrob Chemother; 2016 Jun; 71(6):1643-50. PubMed ID: 26957490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetics and use of Monte Carlo simulation to evaluate currently recommended dosing regimens of ciprofloxacin in adult patients with cystic fibrosis.
    Montgomery MJ; Beringer PM; Aminimanizani A; Louie SG; Shapiro BJ; Jelliffe R; Gill MA
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3468-73. PubMed ID: 11709326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of ciprofloxacin: intravenous and increasing oral doses.
    Bergan T; Thorsteinsson SB; Solberg R; Bjornskau L; Kolstad IM; Johnsen S
    Am J Med; 1987 Apr; 82(4A):97-102. PubMed ID: 3578334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple-dose pharmacokinetics of ciprofloxacin administered intravenously to normal volunteers.
    Gonzalez MA; Moranchel AH; Duran S; Pichardo A; Magana JL; Painter B; Forrest A; Drusano GL
    Antimicrob Agents Chemother; 1985 Aug; 28(2):235-9. PubMed ID: 2939794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationships between renal function and disposition of oral ciprofloxacin.
    Forrest A; Weir M; Plaisance KI; Drusano GL; Leslie J; Standiford HC
    Antimicrob Agents Chemother; 1988 Oct; 32(10):1537-40. PubMed ID: 3190182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of ciprofloxacin in acutely ill and convalescent elderly patients.
    Guay DR; Awni WM; Peterson PK; Obaid S; Breitenbucher R; Matzke GR
    Am J Med; 1987 Apr; 82(4A):124-9. PubMed ID: 3578321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a population pharmacokinetic model and optimal sampling strategies for intravenous ciprofloxacin.
    Forrest A; Ballow CH; Nix DE; Birmingham MC; Schentag JJ
    Antimicrob Agents Chemother; 1993 May; 37(5):1065-72. PubMed ID: 8517693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of intravenous ciprofloxacin in normal and renally impaired subjects.
    Shah A; Lettieri J; Blum R; Millikin S; Sica D; Heller AH
    J Antimicrob Chemother; 1996 Jul; 38(1):103-16. PubMed ID: 8858462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trimethoprim-sulfamethoxazole pharmacokinetics in trauma patients.
    Hess MM; Boucher BA; Laizure SC; Stevens RC; Sanders PL; Janning SW; Croce MA; Fabian TC
    Pharmacotherapy; 1993; 13(6):602-6. PubMed ID: 8302685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does Critical Illness Change Levofloxacin Pharmacokinetics?
    Roberts JA; Cotta MO; Cojutti P; Lugano M; Della Rocca G; Pea F
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1459-63. PubMed ID: 26666946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vancomycin dosing for pneumonia in critically ill trauma patients.
    Patanwala AE; Norris CJ; Nix DE; Kopp BJ; Erstad BL
    J Trauma; 2009 Oct; 67(4):802-4. PubMed ID: 19820588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose ranging study and constant infusion evaluation of ciprofloxacin.
    Drusano GL; Plaisance KI; Forrest A; Standiford HC
    Antimicrob Agents Chemother; 1986 Sep; 30(3):440-3. PubMed ID: 3777907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ciprofloxacin pharmacokinetics in critically ill patients: a prospective cohort study.
    van Zanten AR; Polderman KH; van Geijlswijk IM; van der Meer GY; Schouten MA; Girbes AR
    J Crit Care; 2008 Sep; 23(3):422-30. PubMed ID: 18725050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of higher-dose intravenous ciprofloxacin in severe hospital-acquired infections.
    Kljucar S; Heimesaat M; von Pritzbuer E; Timm J; Scholl H; Beermann D
    Am J Med; 1989 Nov; 87(5A):52S-56S. PubMed ID: 2589385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population Pharmacokinetics of Tigecycline in Critically Ill Patients with Severe Infections.
    Xie J; Roberts JA; Alobaid AS; Roger C; Wang Y; Yang Q; Sun J; Dong H; Wang X; Xing J; Lipman J; Dong Y
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28607024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.